nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—SLCO1A2—Prednisolone—psoriatic arthritis	0.0999	0.122	CbGbCtD
Quinine—SLCO1A2—Prednisone—psoriatic arthritis	0.0944	0.115	CbGbCtD
Quinine—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0589	0.0717	CbGbCtD
Quinine—SLCO1A2—Methotrexate—psoriatic arthritis	0.0473	0.0577	CbGbCtD
Quinine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0421	0.0513	CbGbCtD
Quinine—CYP1A1—Dexamethasone—psoriatic arthritis	0.0408	0.0496	CbGbCtD
Quinine—CYP3A7—Dexamethasone—psoriatic arthritis	0.0326	0.0397	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0326	0.0397	CbGbCtD
Quinine—CYP2C19—Prednisone—psoriatic arthritis	0.0316	0.0385	CbGbCtD
Quinine—CYP2E1—Dexamethasone—psoriatic arthritis	0.0315	0.0383	CbGbCtD
Quinine—ABCB1—Betamethasone—psoriatic arthritis	0.0274	0.0333	CbGbCtD
Quinine—ABCB1—Prednisolone—psoriatic arthritis	0.027	0.0329	CbGbCtD
Quinine—ABCB1—Prednisone—psoriatic arthritis	0.0255	0.0311	CbGbCtD
Quinine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0252	0.0307	CbGbCtD
Quinine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0245	0.0298	CbGbCtD
Quinine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0235	0.0286	CbGbCtD
Quinine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0197	0.024	CbGbCtD
Quinine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0191	0.0233	CbGbCtD
Quinine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0164	0.02	CbGbCtD
Quinine—CYP3A4—Betamethasone—psoriatic arthritis	0.0164	0.02	CbGbCtD
Quinine—CYP3A4—Prednisolone—psoriatic arthritis	0.0162	0.0197	CbGbCtD
Quinine—ABCB1—Dexamethasone—psoriatic arthritis	0.0159	0.0194	CbGbCtD
Quinine—CYP3A4—Prednisone—psoriatic arthritis	0.0153	0.0186	CbGbCtD
Quinine—CYP2D6—Dexamethasone—psoriatic arthritis	0.015	0.0183	CbGbCtD
Quinine—ABCB1—Methotrexate—psoriatic arthritis	0.0128	0.0156	CbGbCtD
Quinine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00954	0.0116	CbGbCtD
Quinine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000386	0.00216	CcSEcCtD
Quinine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000386	0.00216	CcSEcCtD
Quinine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000384	0.00214	CcSEcCtD
Quinine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000383	0.00214	CcSEcCtD
Quinine—Ataxia—Methotrexate—psoriatic arthritis	0.000382	0.00214	CcSEcCtD
Quinine—Vision blurred—Prednisolone—psoriatic arthritis	0.00038	0.00212	CcSEcCtD
Quinine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000375	0.0021	CcSEcCtD
Quinine—Visual impairment—Dexamethasone—psoriatic arthritis	0.000372	0.00208	CcSEcCtD
Quinine—Visual impairment—Betamethasone—psoriatic arthritis	0.000372	0.00208	CcSEcCtD
Quinine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000372	0.00208	CcSEcCtD
Quinine—Erythema—Triamcinolone—psoriatic arthritis	0.000371	0.00207	CcSEcCtD
Quinine—Erythema—Methylprednisolone—psoriatic arthritis	0.00037	0.00207	CcSEcCtD
Quinine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00037	0.00207	CcSEcCtD
Quinine—Angioedema—Prednisolone—psoriatic arthritis	0.000368	0.00206	CcSEcCtD
Quinine—Breast disorder—Methotrexate—psoriatic arthritis	0.000367	0.00205	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000366	0.00205	CcSEcCtD
Quinine—Vertigo—Prednisolone—psoriatic arthritis	0.000362	0.00202	CcSEcCtD
Quinine—Syncope—Prednisolone—psoriatic arthritis	0.000361	0.00202	CcSEcCtD
Quinine—Eye disorder—Betamethasone—psoriatic arthritis	0.000361	0.00202	CcSEcCtD
Quinine—Eye disorder—Dexamethasone—psoriatic arthritis	0.000361	0.00202	CcSEcCtD
Quinine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000354	0.00198	CcSEcCtD
Quinine—Asthma—Methotrexate—psoriatic arthritis	0.000351	0.00196	CcSEcCtD
Quinine—Convulsion—Prednisolone—psoriatic arthritis	0.000349	0.00195	CcSEcCtD
Quinine—Bradycardia—Prednisone—psoriatic arthritis	0.000342	0.00191	CcSEcCtD
Quinine—Angioedema—Triamcinolone—psoriatic arthritis	0.000339	0.00189	CcSEcCtD
Quinine—Haemoglobin—Prednisone—psoriatic arthritis	0.000338	0.00189	CcSEcCtD
Quinine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000338	0.00189	CcSEcCtD
Quinine—Haemorrhage—Prednisone—psoriatic arthritis	0.000336	0.00188	CcSEcCtD
Quinine—Erythema—Betamethasone—psoriatic arthritis	0.000336	0.00188	CcSEcCtD
Quinine—Erythema—Dexamethasone—psoriatic arthritis	0.000336	0.00188	CcSEcCtD
Quinine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000334	0.00186	CcSEcCtD
Quinine—Vertigo—Triamcinolone—psoriatic arthritis	0.000333	0.00186	CcSEcCtD
Quinine—Syncope—Triamcinolone—psoriatic arthritis	0.000332	0.00186	CcSEcCtD
Quinine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000332	0.00186	CcSEcCtD
Quinine—Syncope—Methylprednisolone—psoriatic arthritis	0.000332	0.00185	CcSEcCtD
Quinine—Oedema—Prednisolone—psoriatic arthritis	0.000329	0.00184	CcSEcCtD
Quinine—Neutropenia—Methotrexate—psoriatic arthritis	0.000328	0.00184	CcSEcCtD
Quinine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000326	0.00182	CcSEcCtD
Quinine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000325	0.00182	CcSEcCtD
Quinine—Shock—Prednisolone—psoriatic arthritis	0.000324	0.00181	CcSEcCtD
Quinine—Convulsion—Triamcinolone—psoriatic arthritis	0.000321	0.00179	CcSEcCtD
Quinine—Tachycardia—Prednisolone—psoriatic arthritis	0.000321	0.00179	CcSEcCtD
Quinine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000321	0.00179	CcSEcCtD
Quinine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00032	0.00179	CcSEcCtD
Quinine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000318	0.00178	CcSEcCtD
Quinine—Myalgia—Triamcinolone—psoriatic arthritis	0.000316	0.00176	CcSEcCtD
Quinine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000315	0.00176	CcSEcCtD
Quinine—Eye disorder—Prednisone—psoriatic arthritis	0.000314	0.00176	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000313	0.00175	CcSEcCtD
Quinine—Flushing—Prednisone—psoriatic arthritis	0.000312	0.00174	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000311	0.00174	CcSEcCtD
Quinine—Renal failure—Methotrexate—psoriatic arthritis	0.000308	0.00172	CcSEcCtD
Quinine—Angioedema—Dexamethasone—psoriatic arthritis	0.000307	0.00172	CcSEcCtD
Quinine—Angioedema—Betamethasone—psoriatic arthritis	0.000307	0.00172	CcSEcCtD
Quinine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000304	0.0017	CcSEcCtD
Quinine—Immune system disorder—Prednisone—psoriatic arthritis	0.000304	0.0017	CcSEcCtD
Quinine—Oedema—Triamcinolone—psoriatic arthritis	0.000302	0.00169	CcSEcCtD
Quinine—Vertigo—Betamethasone—psoriatic arthritis	0.000302	0.00169	CcSEcCtD
Quinine—Vertigo—Dexamethasone—psoriatic arthritis	0.000302	0.00169	CcSEcCtD
Quinine—Syncope—Dexamethasone—psoriatic arthritis	0.000302	0.00169	CcSEcCtD
Quinine—Syncope—Betamethasone—psoriatic arthritis	0.000302	0.00169	CcSEcCtD
Quinine—Sweating—Methotrexate—psoriatic arthritis	0.0003	0.00168	CcSEcCtD
Quinine—Shock—Triamcinolone—psoriatic arthritis	0.000298	0.00166	CcSEcCtD
Quinine—Shock—Methylprednisolone—psoriatic arthritis	0.000297	0.00166	CcSEcCtD
Quinine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000296	0.00165	CcSEcCtD
Quinine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000296	0.00165	CcSEcCtD
Quinine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000296	0.00165	CcSEcCtD
Quinine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000295	0.00165	CcSEcCtD
Quinine—Mental disorder—Prednisone—psoriatic arthritis	0.000295	0.00165	CcSEcCtD
Quinine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000295	0.00165	CcSEcCtD
Quinine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000293	0.00164	CcSEcCtD
Quinine—Erythema—Prednisone—psoriatic arthritis	0.000293	0.00164	CcSEcCtD
Quinine—Malnutrition—Prednisone—psoriatic arthritis	0.000293	0.00164	CcSEcCtD
Quinine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000292	0.00163	CcSEcCtD
Quinine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000292	0.00163	CcSEcCtD
Quinine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000292	0.00163	CcSEcCtD
Quinine—Convulsion—Betamethasone—psoriatic arthritis	0.000291	0.00163	CcSEcCtD
Quinine—Convulsion—Dexamethasone—psoriatic arthritis	0.000291	0.00163	CcSEcCtD
Quinine—Myalgia—Betamethasone—psoriatic arthritis	0.000286	0.0016	CcSEcCtD
Quinine—Myalgia—Dexamethasone—psoriatic arthritis	0.000286	0.0016	CcSEcCtD
Quinine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000283	0.00158	CcSEcCtD
Quinine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000282	0.00158	CcSEcCtD
Quinine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000281	0.00157	CcSEcCtD
Quinine—Hepatitis—Methotrexate—psoriatic arthritis	0.000281	0.00157	CcSEcCtD
Quinine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000278	0.00155	CcSEcCtD
Quinine—Vision blurred—Prednisone—psoriatic arthritis	0.000276	0.00154	CcSEcCtD
Quinine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000276	0.00154	CcSEcCtD
Quinine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000276	0.00154	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000275	0.00154	CcSEcCtD
Quinine—Oedema—Dexamethasone—psoriatic arthritis	0.000274	0.00153	CcSEcCtD
Quinine—Oedema—Betamethasone—psoriatic arthritis	0.000274	0.00153	CcSEcCtD
Quinine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000271	0.00151	CcSEcCtD
Quinine—Visual impairment—Methotrexate—psoriatic arthritis	0.000271	0.00151	CcSEcCtD
Quinine—Shock—Betamethasone—psoriatic arthritis	0.00027	0.00151	CcSEcCtD
Quinine—Shock—Dexamethasone—psoriatic arthritis	0.00027	0.00151	CcSEcCtD
Quinine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00027	0.00151	CcSEcCtD
Quinine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000269	0.0015	CcSEcCtD
Quinine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000269	0.0015	CcSEcCtD
Quinine—Agitation—Prednisone—psoriatic arthritis	0.000269	0.0015	CcSEcCtD
Quinine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000269	0.0015	CcSEcCtD
Quinine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000269	0.0015	CcSEcCtD
Quinine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000268	0.0015	CcSEcCtD
Quinine—Tachycardia—Betamethasone—psoriatic arthritis	0.000268	0.0015	CcSEcCtD
Quinine—Angioedema—Prednisone—psoriatic arthritis	0.000268	0.0015	CcSEcCtD
Quinine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000266	0.00149	CcSEcCtD
Quinine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000265	0.00148	CcSEcCtD
Quinine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000265	0.00148	CcSEcCtD
Quinine—Vertigo—Prednisone—psoriatic arthritis	0.000263	0.00147	CcSEcCtD
Quinine—Eye disorder—Methotrexate—psoriatic arthritis	0.000263	0.00147	CcSEcCtD
Quinine—Syncope—Prednisone—psoriatic arthritis	0.000263	0.00147	CcSEcCtD
Quinine—Tinnitus—Methotrexate—psoriatic arthritis	0.000262	0.00147	CcSEcCtD
Quinine—Anorexia—Betamethasone—psoriatic arthritis	0.000262	0.00146	CcSEcCtD
Quinine—Anorexia—Dexamethasone—psoriatic arthritis	0.000262	0.00146	CcSEcCtD
Quinine—Urticaria—Prednisolone—psoriatic arthritis	0.000261	0.00146	CcSEcCtD
Quinine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000261	0.00146	CcSEcCtD
Quinine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000257	0.00144	CcSEcCtD
Quinine—Hypotension—Betamethasone—psoriatic arthritis	0.000256	0.00143	CcSEcCtD
Quinine—Hypotension—Dexamethasone—psoriatic arthritis	0.000256	0.00143	CcSEcCtD
Quinine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000254	0.00142	CcSEcCtD
Quinine—Convulsion—Prednisone—psoriatic arthritis	0.000254	0.00142	CcSEcCtD
Quinine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000253	0.00142	CcSEcCtD
Quinine—Chills—Methotrexate—psoriatic arthritis	0.000252	0.00141	CcSEcCtD
Quinine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00025	0.0014	CcSEcCtD
Quinine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00025	0.0014	CcSEcCtD
Quinine—Myalgia—Prednisone—psoriatic arthritis	0.000249	0.00139	CcSEcCtD
Quinine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000249	0.00139	CcSEcCtD
Quinine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000249	0.00139	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000248	0.00138	CcSEcCtD
Quinine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000247	0.00138	CcSEcCtD
Quinine—Mental disorder—Methotrexate—psoriatic arthritis	0.000246	0.00138	CcSEcCtD
Quinine—Malnutrition—Methotrexate—psoriatic arthritis	0.000245	0.00137	CcSEcCtD
Quinine—Erythema—Methotrexate—psoriatic arthritis	0.000245	0.00137	CcSEcCtD
Quinine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000242	0.00135	CcSEcCtD
Quinine—Urticaria—Triamcinolone—psoriatic arthritis	0.00024	0.00134	CcSEcCtD
Quinine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00024	0.00134	CcSEcCtD
Quinine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000239	0.00134	CcSEcCtD
Quinine—Oedema—Prednisone—psoriatic arthritis	0.000239	0.00134	CcSEcCtD
Quinine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000239	0.00133	CcSEcCtD
Quinine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000239	0.00133	CcSEcCtD
Quinine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000239	0.00133	CcSEcCtD
Quinine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000237	0.00132	CcSEcCtD
Quinine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000237	0.00132	CcSEcCtD
Quinine—Shock—Prednisone—psoriatic arthritis	0.000235	0.00131	CcSEcCtD
Quinine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000234	0.00131	CcSEcCtD
Quinine—Tachycardia—Prednisone—psoriatic arthritis	0.000233	0.0013	CcSEcCtD
Quinine—Skin disorder—Prednisone—psoriatic arthritis	0.000232	0.0013	CcSEcCtD
Quinine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000231	0.00129	CcSEcCtD
Quinine—Vision blurred—Methotrexate—psoriatic arthritis	0.000231	0.00129	CcSEcCtD
Quinine—Anorexia—Prednisone—psoriatic arthritis	0.000228	0.00127	CcSEcCtD
Quinine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000226	0.00126	CcSEcCtD
Quinine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000226	0.00126	CcSEcCtD
Quinine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000224	0.00125	CcSEcCtD
Quinine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000224	0.00125	CcSEcCtD
Quinine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000223	0.00125	CcSEcCtD
Quinine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000222	0.00124	CcSEcCtD
Quinine—Vertigo—Methotrexate—psoriatic arthritis	0.00022	0.00123	CcSEcCtD
Quinine—Leukopenia—Methotrexate—psoriatic arthritis	0.000219	0.00122	CcSEcCtD
Quinine—Urticaria—Betamethasone—psoriatic arthritis	0.000218	0.00122	CcSEcCtD
Quinine—Urticaria—Dexamethasone—psoriatic arthritis	0.000218	0.00122	CcSEcCtD
Quinine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000218	0.00122	CcSEcCtD
Quinine—Dizziness—Prednisolone—psoriatic arthritis	0.000218	0.00122	CcSEcCtD
Quinine—Asthenia—Triamcinolone—psoriatic arthritis	0.000217	0.00121	CcSEcCtD
Quinine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000217	0.00121	CcSEcCtD
Quinine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000217	0.00121	CcSEcCtD
Quinine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000217	0.00121	CcSEcCtD
Quinine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000217	0.00121	CcSEcCtD
Quinine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000217	0.00121	CcSEcCtD
Quinine—Pruritus—Triamcinolone—psoriatic arthritis	0.000214	0.0012	CcSEcCtD
Quinine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000214	0.00119	CcSEcCtD
Quinine—Convulsion—Methotrexate—psoriatic arthritis	0.000212	0.00119	CcSEcCtD
Quinine—Chest pain—Methotrexate—psoriatic arthritis	0.000208	0.00116	CcSEcCtD
Quinine—Myalgia—Methotrexate—psoriatic arthritis	0.000208	0.00116	CcSEcCtD
Quinine—Decreased appetite—Prednisone—psoriatic arthritis	0.000208	0.00116	CcSEcCtD
Quinine—Rash—Prednisolone—psoriatic arthritis	0.000207	0.00116	CcSEcCtD
Quinine—Dermatitis—Prednisolone—psoriatic arthritis	0.000207	0.00116	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000207	0.00116	CcSEcCtD
Quinine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000206	0.00115	CcSEcCtD
Quinine—Headache—Prednisolone—psoriatic arthritis	0.000206	0.00115	CcSEcCtD
Quinine—Confusional state—Methotrexate—psoriatic arthritis	0.000201	0.00113	CcSEcCtD
Quinine—Dizziness—Triamcinolone—psoriatic arthritis	0.0002	0.00112	CcSEcCtD
Quinine—Dizziness—Methylprednisolone—psoriatic arthritis	0.0002	0.00112	CcSEcCtD
Quinine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000197	0.0011	CcSEcCtD
Quinine—Asthenia—Dexamethasone—psoriatic arthritis	0.000197	0.0011	CcSEcCtD
Quinine—Asthenia—Betamethasone—psoriatic arthritis	0.000197	0.0011	CcSEcCtD
Quinine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000196	0.00109	CcSEcCtD
Quinine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000196	0.00109	CcSEcCtD
Quinine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000195	0.00109	CcSEcCtD
Quinine—Nausea—Prednisolone—psoriatic arthritis	0.000195	0.00109	CcSEcCtD
Quinine—Pruritus—Betamethasone—psoriatic arthritis	0.000194	0.00109	CcSEcCtD
Quinine—Pruritus—Dexamethasone—psoriatic arthritis	0.000194	0.00109	CcSEcCtD
Quinine—Skin disorder—Methotrexate—psoriatic arthritis	0.000194	0.00108	CcSEcCtD
Quinine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000193	0.00108	CcSEcCtD
Quinine—Vomiting—Triamcinolone—psoriatic arthritis	0.000192	0.00107	CcSEcCtD
Quinine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000192	0.00107	CcSEcCtD
Quinine—Rash—Triamcinolone—psoriatic arthritis	0.000191	0.00107	CcSEcCtD
Quinine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000191	0.00106	CcSEcCtD
Quinine—Anorexia—Methotrexate—psoriatic arthritis	0.00019	0.00106	CcSEcCtD
Quinine—Rash—Methylprednisolone—psoriatic arthritis	0.00019	0.00106	CcSEcCtD
Quinine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00019	0.00106	CcSEcCtD
Quinine—Urticaria—Prednisone—psoriatic arthritis	0.00019	0.00106	CcSEcCtD
Quinine—Headache—Triamcinolone—psoriatic arthritis	0.000189	0.00106	CcSEcCtD
Quinine—Headache—Methylprednisolone—psoriatic arthritis	0.000189	0.00106	CcSEcCtD
Quinine—Abdominal pain—Prednisone—psoriatic arthritis	0.000189	0.00106	CcSEcCtD
Quinine—Body temperature increased—Prednisone—psoriatic arthritis	0.000189	0.00106	CcSEcCtD
Quinine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000188	0.00105	CcSEcCtD
Quinine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000188	0.00105	CcSEcCtD
Quinine—Hypotension—Methotrexate—psoriatic arthritis	0.000187	0.00104	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000182	0.00102	CcSEcCtD
Quinine—Dizziness—Dexamethasone—psoriatic arthritis	0.000181	0.00101	CcSEcCtD
Quinine—Dizziness—Betamethasone—psoriatic arthritis	0.000181	0.00101	CcSEcCtD
Quinine—Nausea—Triamcinolone—psoriatic arthritis	0.00018	0.001	CcSEcCtD
Quinine—Nausea—Methylprednisolone—psoriatic arthritis	0.000179	0.001	CcSEcCtD
Quinine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000178	0.000995	CcSEcCtD
Quinine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000176	0.000984	CcSEcCtD
Quinine—Vomiting—Betamethasone—psoriatic arthritis	0.000175	0.000975	CcSEcCtD
Quinine—Vomiting—Dexamethasone—psoriatic arthritis	0.000175	0.000975	CcSEcCtD
Quinine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000174	0.00097	CcSEcCtD
Quinine—Rash—Dexamethasone—psoriatic arthritis	0.000173	0.000967	CcSEcCtD
Quinine—Rash—Betamethasone—psoriatic arthritis	0.000173	0.000967	CcSEcCtD
Quinine—Dermatitis—Betamethasone—psoriatic arthritis	0.000173	0.000966	CcSEcCtD
Quinine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000173	0.000966	CcSEcCtD
Quinine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000172	0.000964	CcSEcCtD
Quinine—Headache—Dexamethasone—psoriatic arthritis	0.000172	0.000961	CcSEcCtD
Quinine—Headache—Betamethasone—psoriatic arthritis	0.000172	0.000961	CcSEcCtD
Quinine—Asthenia—Prednisone—psoriatic arthritis	0.000171	0.000958	CcSEcCtD
Quinine—Pruritus—Prednisone—psoriatic arthritis	0.000169	0.000945	CcSEcCtD
Quinine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000165	0.00092	CcSEcCtD
Quinine—Diarrhoea—Prednisone—psoriatic arthritis	0.000164	0.000914	CcSEcCtD
Quinine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000163	0.000913	CcSEcCtD
Quinine—Nausea—Dexamethasone—psoriatic arthritis	0.000163	0.000911	CcSEcCtD
Quinine—Nausea—Betamethasone—psoriatic arthritis	0.000163	0.000911	CcSEcCtD
Quinine—Urticaria—Methotrexate—psoriatic arthritis	0.000159	0.000887	CcSEcCtD
Quinine—Dizziness—Prednisone—psoriatic arthritis	0.000158	0.000883	CcSEcCtD
Quinine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000158	0.000883	CcSEcCtD
Quinine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000158	0.000883	CcSEcCtD
Quinine—Vomiting—Prednisone—psoriatic arthritis	0.000152	0.000849	CcSEcCtD
Quinine—Rash—Prednisone—psoriatic arthritis	0.000151	0.000842	CcSEcCtD
Quinine—Dermatitis—Prednisone—psoriatic arthritis	0.000151	0.000841	CcSEcCtD
Quinine—Headache—Prednisone—psoriatic arthritis	0.00015	0.000837	CcSEcCtD
Quinine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000147	0.000822	CcSEcCtD
Quinine—Asthenia—Methotrexate—psoriatic arthritis	0.000143	0.000801	CcSEcCtD
Quinine—Nausea—Prednisone—psoriatic arthritis	0.000142	0.000793	CcSEcCtD
Quinine—Pruritus—Methotrexate—psoriatic arthritis	0.000141	0.00079	CcSEcCtD
Quinine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000137	0.000764	CcSEcCtD
Quinine—Dizziness—Methotrexate—psoriatic arthritis	0.000132	0.000738	CcSEcCtD
Quinine—Vomiting—Methotrexate—psoriatic arthritis	0.000127	0.00071	CcSEcCtD
Quinine—Rash—Methotrexate—psoriatic arthritis	0.000126	0.000704	CcSEcCtD
Quinine—Dermatitis—Methotrexate—psoriatic arthritis	0.000126	0.000703	CcSEcCtD
Quinine—Headache—Methotrexate—psoriatic arthritis	0.000125	0.000699	CcSEcCtD
Quinine—Nausea—Methotrexate—psoriatic arthritis	0.000119	0.000663	CcSEcCtD
